About this trial
This current comparative study involved 54 patients undergoing thoracoscopic thymectomy who were distributed randomly into three equal groups to receive ultrasound (US)-guided ESPB using 20 ml bupivacaine 0.25% (group B) , 20 ml bupivacaine 0.25% with 8 mg dexamethasone (group BS), 20 ml bupivacaine 0.25% with dexmedetomidine 1mcg/kg (group BM). The time till the first postoperative rescue analgesic requested was the primary outcome. The secondary outcomes included the postoperative pain scores and analgesic consumption.
Eligibility criteria
Qualifiers
myasthenic patients
American Society of Anesthesiologists (ASA) physical grade of 2-3)
who underwent video assisted thoracoscopic thymectomy
Disqualifiers
Refused participation in the study,
known allergy for this study drugs ,
Contraindication to the ESPB as infection at block site & marked chest cage deformity,
significant bleeding disorders ,
Trial design
Treatments tested in this trial
- Erector Spinae Plane Block
- Erector Spinae Plane Block
- Erector Spinae Plane Block